Recent Finacing
Recent Raise
Nora Therapeutics (Palo Alto) develops NT100, a biologic mimicking a reproductive-tract protein to optimize maternal-fetal immune tolerance for embryo implantation and pregnancy maintenance; NT100 is in Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
